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Coupled With Coronary Calcium Scoring*
Leslee J. Shaw, PHDI n this issue of iJACC, Chang et al. (1) report onthe long-term prognostic ﬁndings with coro-nary artery calciﬁcation scoring (CACS) added
to the more conventional exercise electrocardio-
graphic (ECG) diagnostic testing. Although exercise
testing is well established as a diagnostic tool for
coronary artery disease (CAD), CACS also has a well-
developed evidence base in terms of risk stratiﬁca-
tion. However, often physicians have chosen one or
the other of these modalities and not evaluated the
interplay of their ﬁndings for risk-stratiﬁcation pur-
poses. The report by Chang et al. (1) on long-term
prognosis following combined CACS and exercise
ECG testing is quite intriguing.SEE PAGE 134CACS has long been studied to examine the burden
of subclinical atherosclerosis in largely asymptom-
atic, apparently healthy adults (2). Calciﬁed plaque is
considered a marker of stable but more advanced
plaque, with recent evidence noting an inverse rela-
tionship between plaque density and cardiovascular
events (3). This evidence supports the concept that
advanced plaque often contains CAC and may also co-
occur with progressive obstructive CAD states.
Although this is a general pattern of how atheroscle-
rotic disease would progress, CAC does not uniformly
reﬂect an underlying obstructive stenosis (4). The
ﬁndings in this report that CACS is a strong prog-
nosticator is no surprise given that it is a direct
marker of the burden of atherosclerosis on the basis
of computed tomographic ﬁndings. Importantly, the
ﬁndings from the registry of Chang et al. (1) reveal the
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contents of this paper to disclose.outcomes at 7 years—well beyond the short-term
ﬁndings often reported in many prognostic series.
These data underscore the importance of CACS as a
marker of the natural history of atherosclerotic dis-
ease that persists for many years following index
testing.
Conversely, exercise testing examines functional
capacity, and the predictive value of the stress ECG is
on the basis of the concept of demand ischemia. The
primary aim of an exercise test is to provoke ischemia
whereby angina or other symptoms occurring with
arrhythmias or ECG abnormalities would be elicited
during testing in the setting of a ﬂow-limiting lesion.
The exercise ECG ﬁndings can be combined, with
exertional symptoms and functional capacity, into
the Duke treadmill score, which effectively risk-
stratiﬁes patients but also identiﬁes patients’ risk
for severe or extensive CAD (5,6). The report by Chang
et al. (1) states that, due to the improved prognosti-
cation with CACS, this procedure should be the front-
line test instead of the exercise ECG. An important
concept to note is that we no longer have the natural
history of ECG ischemia, as its documentation initi-
ates a series of anti-ischemic therapies post-testing
that subsequently alter its natural history. These
concepts of identifying risk, altering risk with
ischemia-guided management, and reducing the
prognostic signiﬁcance of the exercise ECG are the
intended goals of testing for and treating stable
ischemic heart disease within the diagnostic workup.
In many ways, the fact that we can intervene in
ischemia renders it integral for guided management.
Missing from the discussion by Chang et al. (1) is that
we do not have a similar guided-management
approach following CACS, which is the sole reason
that it remains so prognostically signiﬁcant in this
long-term analysis. The lack of an established thera-
peutic strategy following CACS limits our enthusiasm
for making CACS a front-line test.
Moreover, it would then seem that these 2
markers provide disparate information that, when
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146combined, may prove optimal for prognostication.
It is for this reason that the presentation of the
combined ECG and CACS ﬁndings from the Chang
et al. (1) series is compelling. First, the combination
of exercise testing with CACS has only recently been
evaluated but is intriguing given that these variable
risk markers for atherosclerosis and ischemia may
improve prognostication. From a practical view-
point, combining CACS and exercise testing would
be inexpensive and yet each risk component would
be additive and improve the precision of the diag-
nostic evaluation (7). Second, the authors (1) present
long-term data on the rate of ensuing major CAD
events following index exercise ECG and CACS
ﬁndings. The median follow-up in this cohort was
lengthy with disease progression likely in many pa-
tients. This report (1) tests the limit of a “warranty
period” beyond our usual 2 to 3 years of follow-up.
High-risk CACS and ECG ﬁndings would prompt
near-term preventive management decisions aimed
at reducing long-term risk. The extent to which both
of these factors predict long-term outcomes is
interesting and may reﬂect underutilization of
effective therapeutic strategies or the fact that index
CACS and ECG ﬁndings persistently accelerate dis-
ease and risk throughout a patient’s remaining life
expectancy following index testing.
We have rarely observed long-term data following
CAD imaging, and the report by Chang et al. (1)
illustrates the value of this information in estimating
the longevity of the ﬁndings of this test. Perhaps, we
consider angiographic ﬁndings more often within the
concept of what was observed and our expectations
of what a patient’s disease state and risk would be
years from now. For example, a patient may have had
a 40% lesion 5 years ago, and pondering his or her
current status, we may not view this prior informa-
tion statically but understand the complex interplay
between disease progression, adherence to therapy,
and other factors that have an impact on the changing
paradigm of evolving risk. Yet, for diagnostic testing,
we have very limited data on long-term prognosis
and often view test results in isolation, such as that
the patient had an abnormal exercise test result 5
years ago, but what that means for the patient now
and how that underlying ischemic burden and
breakthrough symptom burden affect the success ofan ischemia-guided strategy are poorly understood.
We often view ischemic ﬁndings as a checklist or as a
gatekeeper to drive anti-ischemic management de-
cisions but not as a factor that should be a part of the
patient’s clinical history for years to come. Perhaps
this has to do with our current knowledge base from
clinical trials in stable ischemic heart disease, which
treated the angiographic burden of disease and not
targeted ischemic ﬁndings such as that guided by
fractional ﬂow measurements (8–10). On the basis of
the ﬁndings from Chang et al. (1), one may envision
the development of a management strategy whereby
the burden of CAC may crudely reﬂect anatomic
burden and, coupled with exercise test ﬁndings,
preliminary ischemia-guided management strategies
may be devised. The interplay between these 2
markers of ischemia and atherosclerosis could form
the basis of a newly developed diagnostic strategy,
the focus of which would not end following the next
referral to an additional noninvasive or invasive
imaging procedure. But these results, given their
longevity in risk prediction, could form the basis of
intensive and serial risk evaluations for years
following an index diagnostic evaluation. As we
progress toward personalized medicine, including
patient-centered imaging, guided diagnostic risk evi-
dence should form the basis of ensuing short- and
long-term management. We and others have advo-
cated that the link between imaging and improving
outcomes is largely indirect, and that outcomes can be
improved only if imaging-guided therapeutic inter-
vention is implemented (11). It is time for research to
progress beyond the usual risk-prediction models and
to move toward the development of diagnostic-
management strategies on the basis of index test
markers, with the aim of long-term risk reduction.
This investigative group lists one coauthor, Maria
Frias, who passed away recently. She was a long-
standing research coordinator working with this
investigative group, and we were blessed to have had
her guide our community and contribute greatly to
the ﬁeld of cardiovascular imaging.
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